Heterozygous Familial Hypercholesterolemia

Circulation. 2016 Apr 5;133(14):e587-9. doi: 10.1161/CIRCULATIONAHA.115.020701.

Authors

Angela Onorato¹, Amy C Sturm²

Affiliations

¹ From The Ohio State University College of Medicine (A.O.), Division of Human Genetics (A.C.S.), and Dorothy M. Davis Heart and Lung Research Institute (A.C.S.), Ohio State University Wexner Medical Center.
² From The Ohio State University College of Medicine (A.O.), Division of Human Genetics (A.C.S.), and Dorothy M. Davis Heart and Lung Research Institute (A.C.S.), Ohio State University Wexner Medical Center. Amy.Sturm@osumc.edu.

PMID: 27045133
DOI: 10.1161/CIRCULATIONAHA.115.020701

No abstract available

Publication types

Review

MeSH terms

Adult
Age of Onset
Atherosclerosis / etiology
Atherosclerosis / prevention & control
Child
Child, Preschool
Cholesterol, LDL / blood
Coronary Disease / etiology
Coronary Disease / prevention & control
Family Health
Female
Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing
Heterozygote
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hyperlipoproteinemia Type II / blood
Hyperlipoproteinemia Type II / complications
Hyperlipoproteinemia Type II / diagnosis
Hyperlipoproteinemia Type II / drug therapy
Hyperlipoproteinemia Type II / genetics*
Infant
Infant, Newborn
Male
Middle Aged

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors